Recently, the development of monovalent and bivalent human IL-2 fusion toxins targeting human CD25+ cells using an advanced, unique diphtheria-toxin-resistant yeast Pichia Pastor-is expression system was reported, showing potent and selective binding affinity to cells expressing high-affinity IL-2R [99]. Here, IL2RA is linked to diphtheria.